Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
Status:
Terminated
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety profile of single intravenous (IV) dose levels of peginesatide in
participants with chronic kidney disease(CKD) not on dialysis.